These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15081416)
1. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma. Duxbury MS; Ito H; Ashley SW; Whang EE Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416 [TBL] [Abstract][Full Text] [Related]
2. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components. Duxbury MS; Ito H; Ashley SW; Whang EE Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158 [TBL] [Abstract][Full Text] [Related]
3. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575 [TBL] [Abstract][Full Text] [Related]
4. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212 [TBL] [Abstract][Full Text] [Related]
6. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Blumenthal RD; Hansen HJ; Goldenberg DM Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051 [TBL] [Abstract][Full Text] [Related]
8. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565 [TBL] [Abstract][Full Text] [Related]
9. Novel Ras pathway inhibitor induces apoptosis and growth inhibition of K-ras-mutated cancer cells in vitro and in vivo. Jasinski P; Zwolak P; Terai K; Dudek AZ Transl Res; 2008 Nov; 152(5):203-12. PubMed ID: 19010291 [TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050 [TBL] [Abstract][Full Text] [Related]
12. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity. Hong KP; Shin MH; Yoon S; Ji GY; Moon YR; Lee OJ; Choi SY; Lee YM; Koo JH; Lee HC; Lee GK; Kim SR; Lee KH; Han HS; Choe KH; Lee KM; Hong JM; Kim SW; Yi JH; Ji HJ; Kim YB; Song HG Biomaterials; 2015 Oct; 67():32-41. PubMed ID: 26204223 [TBL] [Abstract][Full Text] [Related]
14. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673 [TBL] [Abstract][Full Text] [Related]
16. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer of caspase-8 sensitizes human adenocarcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand. Yasui H; Adachi M; Hamada H; Imai K Int J Oncol; 2005 Feb; 26(2):537-44. PubMed ID: 15645141 [TBL] [Abstract][Full Text] [Related]
18. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Saleem M; Kaur S; Kweon MH; Adhami VM; Afaq F; Mukhtar H Carcinogenesis; 2005 Nov; 26(11):1956-64. PubMed ID: 15958516 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756 [TBL] [Abstract][Full Text] [Related]
20. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]